Atrial Fibrillation Susceptibility in Obesity: An Excess Adiposity and Fibrosis Complicity?

Circ Res

Center for Arrhythmia Research, Department of Internal Medicine-Cardiology, University of Michigan, Ann Arbor, MI, USA.

Published: May 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869997PMC
http://dx.doi.org/10.1161/CIRCRESAHA.116.308686DOI Listing

Publication Analysis

Top Keywords

atrial fibrillation
4
fibrillation susceptibility
4
susceptibility obesity
4
obesity excess
4
excess adiposity
4
adiposity fibrosis
4
fibrosis complicity?
4
atrial
1
susceptibility
1
obesity
1

Similar Publications

Atrial and ventricular natriuretic peptides play an important role in the neurohormonal regulation of cardiac function. Plasma levels of these peptides may aid in the diagnosis and prognosis of different cardiac disorders, such as congestive heart failure, ischemic heart disease, and atrial fibrillation. However, the association between elevated pericardial fluid levels of natriuretic peptides and these clinical conditions has not been proven.

View Article and Find Full Text PDF

Atrial Fibrillation after RSV Vaccination Among Older Adults.

Clin Infect Dis

December 2024

Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA.

RSV vaccine clinical trials reported higher frequencies of atrial fibrillation in intervention groups compared to control. In this large, population-based, propensity-matched study, we found RSV vaccine was not associated with increased risk of new-onset or recurrent atrial fibrillation within 1-42 days compared to influenza or Tdap vaccines.

View Article and Find Full Text PDF

Functional mitral regurgitation (MR) is associated with increased cardiovascular morbidity and mortality and over the past decade, the diagnosis of atrial functional mitral regurgitation (aFMR) has been increasingly observed in the elderly, especially in those with atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF). Annular enlargement, perturbations of annular contraction, and atriogenic leaflet tethering distinguish the pathophysiology of aFMR from the one of ventricular origin. However, no consensus provides recommendations regarding the differential diagnosis and the subsequent management of aFMR.

View Article and Find Full Text PDF

We recently reviewed the article titled "Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation" published in Clinical Cardiology by [khan et al.] (1) with great interest. This study addresses a crucial area of clinical practice, and we appreciate the authors' efforts in exploring this topic.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!